In vivo, CHII up-regulated the levels of the hepatic antioxidant enzyme activity, including GR, GST, and GPx (Figures 1AC) in a dose-dependent manner (1/40, 1/20, and 1/10, m/v) in mice
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
It works directly in areas of the brain involved in fullness and food reward, which may help reduce the drive to keep eating, not just how hungry you feel
The safety of the molecule administrated in mice models comparing to other senolytic treatments 23 push to start more clinical studies in various pathologies (Table 1)